The pathogenesis of metabolic disorders may be related to metabolic disorders activating polyol pathways mediated by aldehyde glycase, which eventually lead to decreased activity of Na+/K+-ATPase enzymes mediated by protein kinases, reduces the production of adenosine triphosphate (ATP), and neurofunctional conduction disorders. This evidence concerns the gene WEE1 and Other metabolic disease.